Best of SSO: Practice Changing Studies in GI Surgical Oncology 2019

Activity Description

In this episode of SurgOnc Today, Ajay Maker, MD, Director of Surgical Oncology at AIMMC/Creticos Cancer Center and of the University of Illinois at Chicago, interviews SSO Gastrointestinal Disease Site Work Group members about the most influential papers in GI surgical oncology from 2019. Four conversations cover topics including:

A recent Lancet study about combination chemotherapy for pancreatic cancer
Advanced gastric cancer and perioperative chemotherapy regimens
New therapies for metastatic gastric cancer
An Annals of Surgical Oncology paper about diagnosing GI cancers from circulating tumor DNA

Faculty

Ajay Maker, MD, is the Director of Surgical Oncology at AIMMC/Creticos Cancer Center, and Associate Professor in the Department of Surgery, Division of Surgical Oncology at the University of Illinois at Chicago

Evan S. Glazer, MD, PhD, is Assistant Professor of Surgery and Principal Investigator, Center for Cancer Research at the University of Tennessee Health Science Center

Yanghee Woo, MD, is Director, Gastroenterology Minimally Invasive Therapy Program and Associate Clinical Professor, Division of Surgical Oncology, Department of Surgery at City of Hope

Mio Kitano, MD, is Assistant Professor in the Division of Surgical Oncology and Endocrine Surgery at the University of Texas Health San Antonio

Carlos Chan, MD, PhD, is Assistant Professor of Surgery, Director-Molecular Epidemiology Resource Core, Assistant Professor of Radiation Oncology, Assistant Professor of Surgery, Surgical Oncology and Endocrine Surgery at the University of Iowa

References

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin,and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locallyadvanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.PMID:30982686

“FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer December 20, 2018 N Engl J Med 2018; 379:2395-2406 DOI: 10.1056/NEJMoa1809775”

"Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer." "Ann Surg Oncol. 2019 Jun;26(6):1824-1832. doi: 10.1245/s10434-019-07201-5. Epub 2019 Jan 31. PubMed PMID: 30706231; PubMed Central PMCID: PMC6511310."

“Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a ransomised, double-blind, placebo-controlled, phase 3 trial Lancet Oncol. 2018 Nov;19(11):1437-1448. doi: 10.1016/S1470-2045(18)30739-3. Epub 2018 Oct 21.”

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered